Stockholm - Free Realtime Quote • SEK
Kancera AB (publ) (KAN.ST)
As of 12:47 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-51,782.0000
-47,562.0000
-44,125.0000
-38,988.0000
Financing Cash Flow
41,781.0000
36,190.0000
95,638.0000
82,148.0000
End Cash Position
58,220.0000
95,149.0000
106,521.0000
55,008.0000
Issuance of Capital Stock
42,409.0000
36,759.0000
95,940.0000
93,842.0000
Repayment of Debt
--
--
--
-14,000.0000
Free Cash Flow
-51,782.0000
-47,562.0000
-44,125.0000
-38,988.0000
12/31/2020 - 2/25/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COMBI.ST CombiGene AB (publ)
3.8700
+2.93%
XINT.ST Xintela AB (publ)
0.2820
+2.92%
ELIC.ST Elicera Therapeutics AB (publ)
0.9200
-2.13%
ATORX.ST Alligator Bioscience AB (publ)
0.9080
-0.77%
SPRINT.ST Sprint Bioscience AB (publ)
1.2740
-5.35%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.3375
+3.21%
FLUI.ST Fluicell AB (publ)
0.0894
-1.54%
ONCO.ST Oncopeptides AB (publ)
3.0000
+3.81%
BIOVIC-B.ST Biovica International AB (publ)
1.7000
+5.99%
ACE.ST Ascelia Pharma AB (publ)
10.86
+2.45%